81 related articles for article (PubMed ID: 20107683)
1. Chemoprophylaxis in contacts of patients with leprosy: systematic review and meta-analysis.
Reveiz L; Buendía JA; Téllez D
Rev Panam Salud Publica; 2009 Oct; 26(4):341-9. PubMed ID: 20107683
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of chemoprophylaxis and immunoprophylaxis in leprosy prevention: a systematic review and network meta-analysis of randomized controlled trials.
Tawfik GM; Biala M; Yousef YM; Tiwari R; Dobs M; Lotfy CI; Farrag DA; Hue AT; Yotsu RR; Huy NT
Clin Microbiol Infect; 2021 Dec; 27(12):1754-1761. PubMed ID: 34332107
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of rifampicin chemoprophylaxis in preventing leprosy in patient contacts: a systematic review of quantitative and qualitative evidence.
Ferreira SMB; Yonekura T; Ignotti E; Oliveira LB; Takahashi J; Soares CB
JBI Database System Rev Implement Rep; 2017 Oct; 15(10):2555-2584. PubMed ID: 29035966
[TBL] [Abstract][Full Text] [Related]
4. Chemoprophylaxis is effective in the prevention of leprosy in endemic countries: a systematic review and meta-analysis. MILEP2 Study Group. Mucosal Immunology of Leprosy.
Smith CM; Smith WC
J Infect; 2000 Sep; 41(2):137-42. PubMed ID: 11023757
[TBL] [Abstract][Full Text] [Related]
5. The State of Affairs in Post-Exposure Leprosy Prevention: A Descriptive Meta-Analysis on Immuno- and Chemo-Prophylaxis.
Schoenmakers A; Mieras L; Budiawan T; van Brakel WH
Res Rep Trop Med; 2020; 11():97-117. PubMed ID: 33117053
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of single dose rifampicin in preventing leprosy in close contacts of patients with newly diagnosed leprosy: cluster randomised controlled trial.
Moet FJ; Pahan D; Oskam L; Richardus JH;
BMJ; 2008 Apr; 336(7647):761-4. PubMed ID: 18332051
[TBL] [Abstract][Full Text] [Related]
7. Chemoprophylaxis in contacts of patients with cholera: systematic review and meta-analysis.
Reveiz L; Chapman E; Ramon-Pardo P; Koehlmoos TP; Cuervo LG; Aldighieri S; Chambliss A
PLoS One; 2011; 6(11):e27060. PubMed ID: 22102873
[TBL] [Abstract][Full Text] [Related]
8. Pre-operative endometrial thinning agents before endometrial destruction for heavy menstrual bleeding.
Tan YH; Lethaby A
Cochrane Database Syst Rev; 2013 Nov; (11):CD010241. PubMed ID: 24234875
[TBL] [Abstract][Full Text] [Related]
9. The combined effect of chemoprophylaxis with single dose rifampicin and immunoprophylaxis with BCG to prevent leprosy in contacts of newly diagnosed leprosy cases: a cluster randomized controlled trial (MALTALEP study).
Richardus RA; Alam K; Pahan D; Feenstra SG; Geluk A; Richardus JH
BMC Infect Dis; 2013 Oct; 13():456. PubMed ID: 24088534
[TBL] [Abstract][Full Text] [Related]
10. Patient-related factors predicting the effectiveness of rifampicin chemoprophylaxis in contacts: 6 year follow up of the COLEP cohort in Bangladesh.
Feenstra SG; Pahan D; Moet FJ; Oskam L; Richardus JH
Lepr Rev; 2012 Sep; 83(3):292-304. PubMed ID: 23356030
[TBL] [Abstract][Full Text] [Related]
11. Limited duration acedapsone prophylaxis in leprosy.
Neelan PN; Sirumban P; Sivaprasad N
Indian J Lepr; 1986; 58(2):251-6. PubMed ID: 3543161
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of a chemoprophylactic intervention with single dose rifampicin in contacts of new leprosy patients.
Idema WJ; Majer IM; Pahan D; Oskam L; Polinder S; Richardus JH
PLoS Negl Trop Dis; 2010 Nov; 4(11):e874. PubMed ID: 21072235
[TBL] [Abstract][Full Text] [Related]
13. Rifamycins (rifampicin, rifabutin and rifapentine) compared to isoniazid for preventing tuberculosis in HIV-negative people at risk of active TB.
Sharma SK; Sharma A; Kadhiravan T; Tharyan P
Evid Based Child Health; 2014 Mar; 9(1):169-294. PubMed ID: 25404581
[TBL] [Abstract][Full Text] [Related]
14. Chemoprophylaxis against leprosy: expectations and methodology of a trial.
Vijayakumaran P; Krishnamurthy P; Rao P; Declerq E
Lepr Rev; 2000 Dec; 71 Suppl():S37-40; discussion S40-1. PubMed ID: 11201885
[TBL] [Abstract][Full Text] [Related]
15. Bisphosphonates in multiple myeloma: a network meta-analysis.
Mhaskar R; Redzepovic J; Wheatley K; Clark OA; Miladinovic B; Glasmacher A; Kumar A; Djulbegovic B
Cochrane Database Syst Rev; 2012 May; (5):CD003188. PubMed ID: 22592688
[TBL] [Abstract][Full Text] [Related]
16. The effects of idarubicin versus other anthracyclines for induction therapy of patients with newly diagnosed leukaemia.
Li X; Xu S; Tan Y; Chen J
Cochrane Database Syst Rev; 2015 Jun; (6):CD010432. PubMed ID: 26037486
[TBL] [Abstract][Full Text] [Related]
17. A study on transmission and a trial of chemoprophylaxis in contacts of leprosy patients: design, methodology and recruitment findings of COLEP.
Moet FJ; Oskam L; Faber R; Pahan D; Richardus JH
Lepr Rev; 2004 Dec; 75(4):376-88. PubMed ID: 15682975
[TBL] [Abstract][Full Text] [Related]
18. First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension.
Xue H; Lu Z; Tang WL; Pang LW; Wang GM; Wong GW; Wright JM
Cochrane Database Syst Rev; 2015 Jan; 1():CD008170. PubMed ID: 25577154
[TBL] [Abstract][Full Text] [Related]
19. Chemoprophylaxis of leprosy with rifampicin in contacts of multibacillary patients: study protocol for a randomized controlled trial.
Dos Santos DS; Duppre NC; Sarno EN; Pinheiro RO; Sales AM; Nery JADC; Moraes MO; Camacho LAB
Trials; 2018 Apr; 19(1):244. PubMed ID: 29685164
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
